PA
APLT

Perceptive Advisors’s Applied Therapeutics APLT Stock Holding History

Perceptive Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500,000
Closed -$3.4M – 115
2024
Q1 		$3.4M Hold
500,000
– – 0.06% 97
2023
Q4 		$500K Buy
+500,000
New +$1.24M 0.01% 95

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Perceptive Advisors's APLT Position: Q2 2025 in Review

Perceptive Advisors sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 860,000 shares — an estimated $420K sold.

Perceptive Advisors first reported a position in APLT in Q4 2023 and held it in 6 quarters. The position peaked at $68M in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Perceptive Advisors reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Perceptive Advisors sold 860,000 Applied Therapeutics shares in Q2 2025, an estimated $420K.
  • Perceptive Advisors first reported a position in Applied Therapeutics in Q4 2023 and held it in 6 quarters.
  • Perceptive Advisors's Applied Therapeutics position peaked at $68M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Perceptive Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.